Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Lasa Supergenerics Ltd - 540702 - Board Meeting Intimation for Notice Of Postponement And Intimation Of Board Meeting Of The Company With Additional Agenda As Follows: To Consider And Recommend Dividend For The Financial Year 2020-21.

 Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/05/2021 ,inter alia, to consider and approve To consider and recommend Dividend for the financial year 2020-21 Other agenda items remains same
24-05-2021
Bigul

Lasa Supergenerics Ltd - 540702 - Board Meeting Intimation for Board Meeting Intimation

 Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015 notice is hereby given that Meeting of The Board of Director of the Company is scheduled to be held on Tuesday May 25 2021 to consider, approve and take on record Audited Financial Results of the Company for the quarter and year ended March 31 2021 and/or to discuss any other business/matter with the permission of the Chairman. In accordance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's Code of Conduct, the Trading Window shall continue to remain closed till May 27, 2021.
18-05-2021
Bigul

Lasa Supergenerics Ltd - 540702 - Equity Shareholders Of Lasa Supergenerics Limited To Be Convened As Per The Directions Of The National Company Law Tribunal, Mumbai Bench On Saturday June 12, 2021 At 10:30 A.M.

 Pursuant to the directions of the Mumbai Bench of the National Company Law Tribunal vide its Order dated February 17, 2021 read with Corrigendum Order dated May 3, 2021 in the matter of Company Application No. CA (CAA)/1157/MB-IV/2020, we wish to inform you that a meeting of the Equity shareholders of Lasa Supergenerics Limited ("Transferee Company") will be held on Saturday June 12, 2021 at 10:30 a.m. ("Meeting") through Video Conferencing or Other Audio Visual Means ("VC/ OAVM"),
11-05-2021
Bigul

Lasa Supergenerics Ltd - 540702 - HALF YEARLY CERTIFICATE FROM PRACTICING COMPANY SECRETARY UNDER REG 40(9) OF SEBI (LODR) REGULATIONS 2015.

 Pursuant to Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 we are enclosing herewith the certificate from Amit R. Dadheech & Associates, Practicing Company Secretary for the half year ended March 31, 2021.
26-04-2021
Bigul

Lasa Supergenerics Ltd - 540702 - Shareholding for the Period Ended March 31, 2021

 Lasa Supergenerics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here
21-04-2021
Bigul

Lasa Supergenerics Ltd - 540702 - Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations,2015 For Period March 31, 2021

 This is to certify that in compliance with regulation 7(2) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, all activities in relation to share transfer facility are maintained by our Share Transfer Agent i.e. Bigshare Services Private Limited having permanent SEBI Registration No INR0000001385. This certificate for the half year ended 31st March 2021 is issued in compliance with Regulation 7(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.
19-04-2021
Bigul

Lasa Supergenerics Ltd - 540702 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Please find enclosed herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter and half year ended March 31, 2021 received from Bigshare Services Private Limited, Registrar and Share Transfer Agent of the Company
17-04-2021
Bigul

Lasa Supergenerics Ltd - 540702 - Statement Of Investor Complaints For The Quarter Ended March 2021

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Nidhi KulshtresthaDesignation :- Company Secretary and Compliance Officer
14-04-2021
Bigul

Lasa Supergenerics Ltd - 540702 - Closure of Trading Window

 This is to inform you that as per the Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders in terms of (Prohibition of Insider Trading) Regulations, 2015, as amended, the trading window for dealing in the equity shares of the Company has been closed for designated employees and their immediate relatives w.e.f. April 01, 2021 till 48 hours after the declaration of financial results (both days inclusive) for the Financial and quarter year ended March 31, 2021.
31-03-2021
Bigul

Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

 With reference to our letter dated February 03, 2021 intimating you about the conference call with Analysts/Investors held on February 05, 2021, please find attached the transcript of the aforesaid conference call.
15-02-2021
Next Page
Close

Let's Open Free Demat Account